CN104083544A - 一种西红花活性组分的提取制备方法 - Google Patents
一种西红花活性组分的提取制备方法 Download PDFInfo
- Publication number
- CN104083544A CN104083544A CN201410197197.2A CN201410197197A CN104083544A CN 104083544 A CN104083544 A CN 104083544A CN 201410197197 A CN201410197197 A CN 201410197197A CN 104083544 A CN104083544 A CN 104083544A
- Authority
- CN
- China
- Prior art keywords
- stigma croci
- extraction
- active component
- pvp
- countercurrent extraction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000605 extraction Methods 0.000 title claims abstract description 74
- 238000002360 preparation method Methods 0.000 title claims abstract description 10
- 235000015655 Crocus sativus Nutrition 0.000 title abstract 5
- 244000124209 Crocus sativus Species 0.000 title abstract 5
- 238000000034 method Methods 0.000 claims abstract description 26
- 239000002904 solvent Substances 0.000 claims abstract description 25
- 239000007864 aqueous solution Substances 0.000 claims abstract description 17
- 238000004108 freeze drying Methods 0.000 claims abstract description 17
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 claims description 35
- 239000000463 material Substances 0.000 claims description 19
- 239000012567 medical material Substances 0.000 claims description 16
- 239000000243 solution Substances 0.000 claims description 15
- 229920001983 poloxamer Polymers 0.000 claims description 9
- ODLHGICHYURWBS-LKONHMLTSA-N trappsol cyclo Chemical compound CC(O)COC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)COCC(O)C)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1COCC(C)O ODLHGICHYURWBS-LKONHMLTSA-N 0.000 claims description 8
- RVGRUAULSDPKGF-UHFFFAOYSA-N Poloxamer Chemical compound C1CO1.CC1CO1 RVGRUAULSDPKGF-UHFFFAOYSA-N 0.000 claims description 7
- 239000002202 Polyethylene glycol Substances 0.000 claims description 7
- 238000002156 mixing Methods 0.000 claims description 7
- 229960000502 poloxamer Drugs 0.000 claims description 7
- 229920001223 polyethylene glycol Polymers 0.000 claims description 7
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims description 7
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims description 7
- 239000001267 polyvinylpyrrolidone Substances 0.000 claims description 7
- 229920001030 Polyethylene Glycol 4000 Polymers 0.000 claims description 6
- 239000000843 powder Substances 0.000 claims description 5
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical class O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 claims description 5
- YZOUYRAONFXZSI-SBHWVFSVSA-N (1S,3R,5R,6R,8R,10R,11R,13R,15R,16R,18R,20R,21R,23R,25R,26R,28R,30R,31S,33R,35R,36R,37S,38R,39S,40R,41S,42R,43S,44R,45S,46R,47S,48R,49S)-5,10,15,20,25,30,35-heptakis(hydroxymethyl)-37,39,40,41,42,43,44,45,46,47,48,49-dodecamethoxy-2,4,7,9,12,14,17,19,22,24,27,29,32,34-tetradecaoxaoctacyclo[31.2.2.23,6.28,11.213,16.218,21.223,26.228,31]nonatetracontane-36,38-diol Chemical compound O([C@@H]([C@H]([C@@H]1OC)OC)O[C@H]2[C@@H](O)[C@@H]([C@@H](O[C@@H]3[C@@H](CO)O[C@@H]([C@H]([C@@H]3O)OC)O[C@@H]3[C@@H](CO)O[C@@H]([C@H]([C@@H]3OC)OC)O[C@@H]3[C@@H](CO)O[C@@H]([C@H]([C@@H]3OC)OC)O[C@@H]3[C@@H](CO)O[C@@H]([C@H]([C@@H]3OC)OC)O3)O[C@@H]2CO)OC)[C@H](CO)[C@H]1O[C@@H]1[C@@H](OC)[C@H](OC)[C@H]3[C@@H](CO)O1 YZOUYRAONFXZSI-SBHWVFSVSA-N 0.000 claims description 4
- 229920000858 Cyclodextrin Polymers 0.000 claims description 4
- PCWPQSDFNIFUPO-VDQKLNDWSA-N (1S,3R,5R,6S,8R,10R,11S,13R,15R,16S,18R,20R,21S,23R,25R,26S,28R,30R,31S,33R,35R,36R,37S,38R,39S,40R,41S,42R,43S,44R,45S,46R,47S,48R,49S)-37,39,41,43,45,47,49-heptakis(2-hydroxyethoxy)-5,10,15,20,25,30,35-heptakis(hydroxymethyl)-2,4,7,9,12,14,17,19,22,24,27,29,32,34-tetradecaoxaoctacyclo[31.2.2.23,6.28,11.213,16.218,21.223,26.228,31]nonatetracontane-36,38,40,42,44,46,48-heptol Chemical compound OCCO[C@H]1[C@H](O)[C@@H]2O[C@H]3O[C@H](CO)[C@@H](O[C@H]4O[C@H](CO)[C@@H](O[C@H]5O[C@H](CO)[C@@H](O[C@H]6O[C@H](CO)[C@@H](O[C@H]7O[C@H](CO)[C@@H](O[C@H]8O[C@H](CO)[C@@H](O[C@H]1O[C@@H]2CO)[C@@H](O)[C@@H]8OCCO)[C@@H](O)[C@@H]7OCCO)[C@@H](O)[C@@H]6OCCO)[C@@H](O)[C@@H]5OCCO)[C@@H](O)[C@@H]4OCCO)[C@@H](O)[C@@H]3OCCO PCWPQSDFNIFUPO-VDQKLNDWSA-N 0.000 claims description 2
- 229920001450 Alpha-Cyclodextrin Polymers 0.000 claims description 2
- 239000008118 PEG 6000 Substances 0.000 claims description 2
- 229920002511 Poloxamer 237 Polymers 0.000 claims description 2
- 229920002584 Polyethylene Glycol 6000 Polymers 0.000 claims description 2
- 229920002594 Polyethylene Glycol 8000 Polymers 0.000 claims description 2
- HFHDHCJBZVLPGP-RWMJIURBSA-N alpha-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO HFHDHCJBZVLPGP-RWMJIURBSA-N 0.000 claims description 2
- 229940043377 alpha-cyclodextrin Drugs 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 abstract description 6
- 238000005516 engineering process Methods 0.000 abstract description 4
- 238000009776 industrial production Methods 0.000 abstract 1
- 239000007788 liquid Substances 0.000 abstract 1
- 239000002861 polymer material Substances 0.000 abstract 1
- 238000004904 shortening Methods 0.000 abstract 1
- 229930182470 glycoside Natural products 0.000 description 56
- 150000002338 glycosides Chemical class 0.000 description 56
- SGAWOGXMMPSZPB-UHFFFAOYSA-N safranal Chemical compound CC1=C(C=O)C(C)(C)CC=C1 SGAWOGXMMPSZPB-UHFFFAOYSA-N 0.000 description 10
- SEBIKDIMAPSUBY-ARYZWOCPSA-N Crocin Chemical compound C([C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O)OC(=O)C(C)=CC=CC(C)=C\C=C\C=C(/C)\C=C\C=C(C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)O1)O)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O SEBIKDIMAPSUBY-ARYZWOCPSA-N 0.000 description 8
- SEBIKDIMAPSUBY-JAUCNNNOSA-N Crocin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C(=O)OC1OC(COC2OC(CO)C(O)C(O)C2O)C(O)C(O)C1O)C=CC=C(/C)C(=O)OC3OC(COC4OC(CO)C(O)C(O)C4O)C(O)C(O)C3O SEBIKDIMAPSUBY-JAUCNNNOSA-N 0.000 description 8
- 239000000284 extract Substances 0.000 description 8
- 238000012360 testing method Methods 0.000 description 8
- 235000013305 food Nutrition 0.000 description 6
- 238000001514 detection method Methods 0.000 description 5
- 235000017509 safranal Nutrition 0.000 description 5
- SEBIKDIMAPSUBY-UHFFFAOYSA-N bis[3,4,5-trihydroxy-6-[[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl] 2,6,11,15-tetramethylhexadeca-2,4,6,8,10,12,14-heptaenedioate Chemical class O1C(COC2C(C(O)C(O)C(CO)O2)O)C(O)C(O)C(O)C1OC(=O)C(C)=CC=CC(C)=CC=CC=C(C)C=CC=C(C)C(=O)OC(C(C(O)C1O)O)OC1COC1OC(CO)C(O)C(O)C1O SEBIKDIMAPSUBY-UHFFFAOYSA-N 0.000 description 4
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 238000000205 computational method Methods 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 239000006286 aqueous extract Substances 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000002386 leaching Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000000178 monomer Substances 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 235000003255 Carthamus tinctorius Nutrition 0.000 description 1
- 244000020518 Carthamus tinctorius Species 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 208000026139 Memory disease Diseases 0.000 description 1
- WMHJCSAICLADIN-MVVLZTAMSA-N Picrocrocin Natural products O=CC=1C(C)(C)C[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O2)CC=1C WMHJCSAICLADIN-MVVLZTAMSA-N 0.000 description 1
- -1 Polyene Hydrocarbons Chemical class 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- 229960000583 acetic acid Drugs 0.000 description 1
- WEVYAHXRMPXWCK-UHFFFAOYSA-N acetonitrile Substances CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- PANKHBYNKQNAHN-MQQNZMFNSA-N crocetin Chemical compound OC(=O)C(/C)=C/C=C/C(/C)=C/C=C/C=C(\C)/C=C/C=C(\C)C(O)=O PANKHBYNKQNAHN-MQQNZMFNSA-N 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 201000005917 gastric ulcer Diseases 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 230000004770 neurodegeneration Effects 0.000 description 1
- 208000015122 neurodegenerative disease Diseases 0.000 description 1
- WMHJCSAICLADIN-WYWSWGBSSA-N picrocrocin Chemical compound C1C(C)=C(C=O)C(C)(C)C[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 WMHJCSAICLADIN-WYWSWGBSSA-N 0.000 description 1
- 208000020016 psychiatric disease Diseases 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
Abstract
Description
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410197197.2A CN104083544B (zh) | 2014-05-09 | 2014-05-09 | 一种西红花活性组分的提取制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410197197.2A CN104083544B (zh) | 2014-05-09 | 2014-05-09 | 一种西红花活性组分的提取制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104083544A true CN104083544A (zh) | 2014-10-08 |
CN104083544B CN104083544B (zh) | 2017-06-06 |
Family
ID=51631372
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410197197.2A Active CN104083544B (zh) | 2014-05-09 | 2014-05-09 | 一种西红花活性组分的提取制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104083544B (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112940056A (zh) * | 2021-02-03 | 2021-06-11 | 上海诗丹德标准技术服务有限公司 | 苦番红花素的对照品的制备方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101422612A (zh) * | 2007-10-30 | 2009-05-06 | 中国科学院过程工程研究所 | 一种提高西红花酸水溶性的方法 |
EP2255782A1 (en) * | 2009-05-25 | 2010-12-01 | Keune Haircosmetics Manufacturing B.V. | Composition for the prevention or treatment of hair loss, and method of preparation |
JP2014012645A (ja) * | 2012-07-04 | 2014-01-23 | Kao Corp | キューティクル細胞分化促進剤 |
-
2014
- 2014-05-09 CN CN201410197197.2A patent/CN104083544B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101422612A (zh) * | 2007-10-30 | 2009-05-06 | 中国科学院过程工程研究所 | 一种提高西红花酸水溶性的方法 |
EP2255782A1 (en) * | 2009-05-25 | 2010-12-01 | Keune Haircosmetics Manufacturing B.V. | Composition for the prevention or treatment of hair loss, and method of preparation |
JP2014012645A (ja) * | 2012-07-04 | 2014-01-23 | Kao Corp | キューティクル細胞分化促進剤 |
Non-Patent Citations (2)
Title |
---|
K SELIM: ""Kinetic studies of degradation of saffron carotenoids encapsulated in amorphous polymer matrices"", 《FOOD CHEMISTRY》 * |
梁华正: ""反相高效液相色谱法同时测定西红花苷和西红花酸"", 《东华理工大学学报》 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112940056A (zh) * | 2021-02-03 | 2021-06-11 | 上海诗丹德标准技术服务有限公司 | 苦番红花素的对照品的制备方法 |
CN112940056B (zh) * | 2021-02-03 | 2023-02-03 | 上海诗丹德标准技术服务有限公司 | 苦番红花素的对照品的制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN104083544B (zh) | 2017-06-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Vieira et al. | Enhanced extraction of phenolic compounds using choline chloride based deep eutectic solvents from Juglans regia L. | |
Ahuja et al. | Application of response surface methodology to formulation of ionotropically gelled gum cordia/gellan beads | |
Li et al. | Screening of a functional polysaccharide from Zizyphus Jujuba cv. Jinsixiaozao and its property | |
Xiang et al. | Hypoglycemic polysaccharides from Auricularia auricula and Auricularia polytricha inhibit oxidative stress, NF-κB signaling and proinflammatory cytokine production in streptozotocin-induced diabetic mice | |
Jena et al. | Organic acids from leaves, fruits, and rinds of Garcinia cowa | |
Salleh et al. | Optimization of alkaline hydrolysis of paddy straw for ferulic acid extraction | |
Bairwa et al. | Nanoparticle formulation of 11-keto-β-boswellic acid (KBA): Anti-inflammatory activity and in vivo pharmacokinetics | |
CN106924350B (zh) | 一种桑葚提取物及其制备方法和应用 | |
Kim et al. | Simultaneous determination of phenoxyethanol and its major metabolite, phenoxyacetic acid, in rat biological matrices by LC–MS/MS with polarity switching: Application to ADME studies | |
CN103848875A (zh) | 一种龙胆苦苷原料的制备方法 | |
Zhang et al. | Protective effects of flavonoids isolated from Agrocybe aegirita on dextran sodium sulfate‐induced colitis | |
CN104326912A (zh) | 一种烟叶有效成分的分离方法 | |
CN104083544A (zh) | 一种西红花活性组分的提取制备方法 | |
Zhang et al. | Polysaccharide extract from Rosa laevigata fruit attenuates inflammatory obesity by targeting redox balance and gut interface in high-fat diet-fed rats | |
Chen et al. | Antibacterial, anti‐inflammatory, analgesic, and hemostatic activities of Acanthopanax trifoliatus (L.) merr | |
CN101306134B (zh) | 复方南星止痛膏巴布剂组合物及其制备方法 | |
CN103787885B (zh) | 一种从金银花地上部分提取高纯度绿原酸的方法 | |
Xu et al. | Identification of anti-photoaging components of Olea europaea leaves based on spectrum-effect relationship | |
CN108047349A (zh) | 一种卷边桩菇多糖提取物及其制备方法和医用用途 | |
CN107996374A (zh) | 一种通过盐胁迫提高丹参根中丹参酮含量的方法 | |
Svingou et al. | Chios mastic gum: A validated method towards authentication | |
CN102998386A (zh) | 一种用高效液相色谱测定白芍愈伤组织中白芍双苷的方法 | |
CN103012510A (zh) | 一种1,2,3,4,6-五没食子酰葡萄糖对照品的制备方法 | |
CN107746419B (zh) | 一种苹果花有效部位、制备方法及利用其提取山奈酚葡萄糖苷的方法 | |
CN101874792B (zh) | 间苯三酚口腔崩解片及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CP03 | Change of name, title or address | ||
CP03 | Change of name, title or address |
Address after: Room 204-2, Building 3, No.1 Luting Road, Cangqian Street, Yuhang District, Hangzhou City, Zhejiang Province, 311201 Patentee after: ZHEJIANG JIURUTANG BIOTECHNOLOGY CO.,LTD. Country or region after: China Address before: Room 603A, Haichuangyuan, No. 998 Wenyi West Road, Xihu District, Hangzhou City, Zhejiang Province, 311121 Patentee before: HANGZHOU JIURUTANG BIOTECHNOLOGY Co.,Ltd. Country or region before: China |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20240514 Address after: 321000 2nd floor, office quality inspection building, building X02, No. 58, GAOFAN section, Baitang line, Wucheng District, Jinhua City, Zhejiang Province Patentee after: ZHEJIANG JIANFENG PHARMACEUTICAL CO.,LTD. Country or region after: China Address before: Room 204-2, Building 3, No.1 Luting Road, Cangqian Street, Yuhang District, Hangzhou City, Zhejiang Province, 311201 Patentee before: ZHEJIANG JIURUTANG BIOTECHNOLOGY CO.,LTD. Country or region before: China |